Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Marfan Syndrome | 24 | 2023 | 236 | 4.520 |
Why?
|
Atenolol | 12 | 2020 | 99 | 3.130 |
Why?
|
Losartan | 12 | 2020 | 265 | 2.800 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 10 | 2020 | 435 | 2.350 |
Why?
|
Aorta | 11 | 2023 | 2039 | 1.520 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2022 | 1259 | 1.310 |
Why?
|
Connective Tissue Diseases | 4 | 2017 | 286 | 1.240 |
Why?
|
Aortic Diseases | 8 | 2024 | 734 | 1.180 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 4 | 2020 | 30 | 0.920 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2015 | 693 | 0.900 |
Why?
|
Aortic Aneurysm | 4 | 2015 | 646 | 0.820 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2021 | 47 | 0.730 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2021 | 313 | 0.680 |
Why?
|
Chromosome Deletion | 2 | 2023 | 1387 | 0.560 |
Why?
|
Vertebral Artery | 2 | 2014 | 185 | 0.460 |
Why?
|
Skin Diseases, Genetic | 1 | 2014 | 49 | 0.450 |
Why?
|
Noonan Syndrome | 2 | 2014 | 120 | 0.440 |
Why?
|
Heart Valve Diseases | 3 | 2023 | 1047 | 0.430 |
Why?
|
Aortic Valve | 7 | 2023 | 1996 | 0.390 |
Why?
|
Infant | 32 | 2024 | 36053 | 0.380 |
Why?
|
Aneurysm | 1 | 2014 | 337 | 0.380 |
Why?
|
Arteries | 2 | 2023 | 1126 | 0.370 |
Why?
|
Child, Preschool | 36 | 2024 | 42056 | 0.360 |
Why?
|
Loeys-Dietz Syndrome | 3 | 2023 | 40 | 0.350 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2716 | 0.340 |
Why?
|
Vascular Malformations | 1 | 2014 | 464 | 0.320 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2255 | 0.310 |
Why?
|
Dilatation, Pathologic | 4 | 2020 | 527 | 0.290 |
Why?
|
Joint Instability | 1 | 2014 | 795 | 0.280 |
Why?
|
Echocardiography | 9 | 2023 | 4981 | 0.270 |
Why?
|
Child | 31 | 2024 | 79799 | 0.270 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2011 | 491 | 0.220 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 584 | 0.220 |
Why?
|
Heart Septal Defects, Atrial | 3 | 2011 | 461 | 0.220 |
Why?
|
Chromosome Disorders | 4 | 2023 | 499 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 3 | 2015 | 1431 | 0.210 |
Why?
|
Ectopia Lentis | 1 | 2022 | 20 | 0.200 |
Why?
|
Adolescent | 24 | 2024 | 87809 | 0.200 |
Why?
|
Collagen Type V | 1 | 2021 | 16 | 0.190 |
Why?
|
Transcription Factors | 1 | 2021 | 12102 | 0.190 |
Why?
|
Mitral Valve Insufficiency | 4 | 2018 | 1419 | 0.180 |
Why?
|
Collagen Type III | 1 | 2021 | 91 | 0.180 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 51 | 0.180 |
Why?
|
Dwarfism | 1 | 2021 | 137 | 0.170 |
Why?
|
Aortic Coarctation | 2 | 2015 | 282 | 0.170 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8055 | 0.170 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 1046 | 0.160 |
Why?
|
Female | 45 | 2023 | 391246 | 0.160 |
Why?
|
Male | 41 | 2023 | 359718 | 0.160 |
Why?
|
Phenotype | 7 | 2023 | 16548 | 0.150 |
Why?
|
Young Adult | 12 | 2020 | 58748 | 0.150 |
Why?
|
Humans | 68 | 2024 | 760613 | 0.150 |
Why?
|
Thinness | 1 | 2021 | 491 | 0.140 |
Why?
|
Aorta, Thoracic | 2 | 2017 | 1095 | 0.140 |
Why?
|
Retrospective Studies | 14 | 2020 | 80345 | 0.140 |
Why?
|
Microcephaly | 1 | 2021 | 425 | 0.140 |
Why?
|
Adult | 22 | 2023 | 220007 | 0.130 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4716 | 0.130 |
Why?
|
Infant, Newborn | 16 | 2023 | 26179 | 0.130 |
Why?
|
Aortic Valve Stenosis | 3 | 2020 | 2065 | 0.130 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2018 | 578 | 0.130 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2015 | 38 | 0.120 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1570 | 0.120 |
Why?
|
Face | 1 | 2021 | 1017 | 0.120 |
Why?
|
Heart Defects, Congenital | 5 | 2018 | 4673 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2022 | 1031 | 0.110 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2015 | 218 | 0.110 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2018 | 613 | 0.100 |
Why?
|
Intestinal Polyposis | 1 | 2012 | 42 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2022 | 1523 | 0.100 |
Why?
|
Gestational Age | 1 | 2021 | 3564 | 0.100 |
Why?
|
Antihypertensive Agents | 2 | 2018 | 2061 | 0.100 |
Why?
|
Smad4 Protein | 1 | 2012 | 191 | 0.100 |
Why?
|
Echocardiography, Doppler | 2 | 2012 | 901 | 0.100 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 71 | 0.090 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2012 | 141 | 0.090 |
Why?
|
Linear Models | 3 | 2018 | 5877 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2011 | 191 | 0.090 |
Why?
|
Pilot Projects | 3 | 2020 | 8556 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 3 | 2011 | 3620 | 0.090 |
Why?
|
Heart | 1 | 2023 | 4393 | 0.090 |
Why?
|
Pulmonary Artery | 2 | 2013 | 1921 | 0.090 |
Why?
|
Patient Compliance | 1 | 2020 | 2688 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1376 | 0.090 |
Why?
|
Mitral Valve | 1 | 2018 | 1486 | 0.090 |
Why?
|
Abnormalities, Multiple | 6 | 2011 | 1415 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39262 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1469 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2018 | 64981 | 0.080 |
Why?
|
Enalapril | 1 | 2011 | 313 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10343 | 0.080 |
Why?
|
Heart Ventricles | 2 | 2018 | 3812 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15840 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4279 | 0.080 |
Why?
|
Lymphangioma | 1 | 1988 | 61 | 0.070 |
Why?
|
Genotype | 3 | 2022 | 12957 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15760 | 0.070 |
Why?
|
Down Syndrome | 2 | 2018 | 892 | 0.070 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 1987 | 38 | 0.070 |
Why?
|
Genitalia, Female | 1 | 1988 | 147 | 0.070 |
Why?
|
American Heart Association | 2 | 2024 | 1081 | 0.070 |
Why?
|
Heart Block | 1 | 2008 | 392 | 0.070 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2011 | 594 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1765 | 0.070 |
Why?
|
Turner Syndrome | 1 | 1988 | 130 | 0.070 |
Why?
|
Catheterization | 1 | 2012 | 1432 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20080 | 0.070 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1388 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 611 | 0.070 |
Why?
|
Umbilical Cord | 1 | 1987 | 181 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1894 | 0.060 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1987 | 363 | 0.060 |
Why?
|
Mutation | 5 | 2022 | 29957 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 3 | 2002 | 1745 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 1987 | 360 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6831 | 0.060 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2007 | 316 | 0.060 |
Why?
|
Edema | 1 | 1988 | 770 | 0.060 |
Why?
|
United States | 7 | 2024 | 72448 | 0.050 |
Why?
|
Williams Syndrome | 2 | 2013 | 193 | 0.050 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2011 | 354 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3617 | 0.050 |
Why?
|
Age Factors | 3 | 2015 | 18413 | 0.050 |
Why?
|
Chromosome Aberrations | 2 | 1999 | 1767 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2023 | 346 | 0.050 |
Why?
|
Carcinoma, Basal Cell | 1 | 1987 | 559 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11902 | 0.050 |
Why?
|
Hospitals, Pediatric | 1 | 2011 | 1854 | 0.050 |
Why?
|
Infant, Premature, Diseases | 1 | 2007 | 708 | 0.050 |
Why?
|
Hernia, Diaphragmatic | 1 | 2002 | 246 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 13308 | 0.050 |
Why?
|
Dextrocardia | 1 | 2000 | 37 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13505 | 0.040 |
Why?
|
Cardiovascular Abnormalities | 1 | 1999 | 143 | 0.040 |
Why?
|
Cardiomegaly | 1 | 2001 | 593 | 0.040 |
Why?
|
Prognosis | 3 | 2018 | 29661 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2019 | 1832 | 0.040 |
Why?
|
Dilatation | 1 | 2018 | 307 | 0.030 |
Why?
|
Research Design | 2 | 2015 | 6180 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2019 | 6065 | 0.030 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2017 | 92 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1495 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2020 | 784 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3465 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
Prospective Studies | 7 | 2023 | 54306 | 0.030 |
Why?
|
Aneuploidy | 1 | 2018 | 551 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1218 | 0.030 |
Why?
|
Death, Sudden | 1 | 1996 | 302 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.030 |
Why?
|
Middle Aged | 5 | 2023 | 220359 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2005 | 1582 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3315 | 0.030 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2013 | 28 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6552 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2514 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 1988 | 2882 | 0.030 |
Why?
|
Risk Assessment | 4 | 2018 | 24102 | 0.030 |
Why?
|
Alagille Syndrome | 1 | 2013 | 45 | 0.030 |
Why?
|
Phosphoglucomutase | 1 | 1992 | 6 | 0.030 |
Why?
|
Risk Factors | 4 | 2018 | 74333 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 968 | 0.030 |
Why?
|
Calsequestrin | 1 | 1992 | 30 | 0.030 |
Why?
|
Lung | 2 | 2002 | 9994 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2012 | 167 | 0.030 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1992 | 163 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 652 | 0.020 |
Why?
|
Fetal Death | 2 | 1999 | 434 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2668 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 301 | 0.020 |
Why?
|
Stroke Volume | 2 | 2018 | 5523 | 0.020 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.020 |
Why?
|
Hemodynamics | 2 | 2013 | 4173 | 0.020 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1098 | 0.020 |
Why?
|
Chromosome Duplication | 1 | 2011 | 75 | 0.020 |
Why?
|
Genes, Dominant | 2 | 1998 | 863 | 0.020 |
Why?
|
Angioplasty | 1 | 2013 | 360 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4408 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3568 | 0.020 |
Why?
|
Fetus | 3 | 2002 | 1859 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2013 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4899 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12810 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 473 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 494 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2165 | 0.020 |
Why?
|
Carbamazepine | 1 | 1989 | 224 | 0.020 |
Why?
|
DNA | 2 | 2020 | 7233 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1512 | 0.020 |
Why?
|
Orofaciodigital Syndromes | 1 | 1987 | 21 | 0.020 |
Why?
|
Isoenzymes | 1 | 1992 | 1690 | 0.020 |
Why?
|
Pedigree | 3 | 1998 | 4578 | 0.020 |
Why?
|
Branchial Region | 1 | 1987 | 35 | 0.020 |
Why?
|
Situs Inversus | 1 | 1987 | 63 | 0.020 |
Why?
|
Muscles | 1 | 1992 | 1581 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15679 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1135 | 0.020 |
Why?
|
Surface-Active Agents | 1 | 2007 | 150 | 0.020 |
Why?
|
Microphthalmos | 1 | 1987 | 58 | 0.020 |
Why?
|
Reoperation | 2 | 2010 | 4289 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6544 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13312 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7475 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 2294 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2818 | 0.020 |
Why?
|
Length of Stay | 2 | 2010 | 6476 | 0.020 |
Why?
|
Base Sequence | 3 | 2011 | 12444 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1989 | 338 | 0.020 |
Why?
|
Hand Deformities, Congenital | 1 | 1987 | 174 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2893 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2010 | 5418 | 0.020 |
Why?
|
Genome, Human | 1 | 2019 | 4418 | 0.020 |
Why?
|
Twins | 1 | 1987 | 339 | 0.020 |
Why?
|
Syndrome | 4 | 1998 | 3280 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 355 | 0.020 |
Why?
|
Lip | 1 | 1987 | 197 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10826 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2126 | 0.020 |
Why?
|
Placenta Diseases | 1 | 1987 | 196 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3598 | 0.020 |
Why?
|
Karyotyping | 1 | 1987 | 1172 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1959 | 0.020 |
Why?
|
Abortion, Induced | 2 | 2002 | 460 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2505 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 1996 | 1951 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.010 |
Why?
|
X Chromosome | 1 | 1987 | 815 | 0.010 |
Why?
|
Facial Expression | 1 | 1987 | 508 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1992 | 2440 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12531 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4108 | 0.010 |
Why?
|
Growth Disorders | 1 | 1987 | 653 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3531 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1987 | 2381 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
Spleen | 1 | 1987 | 2298 | 0.010 |
Why?
|
Functional Laterality | 1 | 1987 | 2253 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4286 | 0.010 |
Why?
|
Gene Expression | 1 | 1992 | 7587 | 0.010 |
Why?
|
Myocardium | 1 | 1992 | 4700 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1206 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 115 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15790 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4611 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 1999 | 119 | 0.010 |
Why?
|
Pregnancy | 4 | 2000 | 29746 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 3880 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9716 | 0.010 |
Why?
|
Placenta | 1 | 1987 | 1702 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 41337 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2699 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7064 | 0.010 |
Why?
|
Toes | 1 | 1998 | 209 | 0.010 |
Why?
|
Prevalence | 2 | 2008 | 15686 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9591 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2254 | 0.010 |
Why?
|
Maternal Age | 1 | 1999 | 807 | 0.010 |
Why?
|
Scalp | 1 | 1998 | 389 | 0.010 |
Why?
|
Fingers | 1 | 1998 | 506 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10553 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1981 | 1577 | 0.010 |
Why?
|
Ventricular Outflow Obstruction | 1 | 1996 | 265 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1996 | 256 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21391 | 0.010 |
Why?
|
Nephrocalcinosis | 1 | 1993 | 52 | 0.010 |
Why?
|
Chromatography | 1 | 1992 | 189 | 0.010 |
Why?
|
Hydroxyapatites | 1 | 1992 | 73 | 0.010 |
Why?
|
Calcium-Transporting ATPases | 1 | 1992 | 122 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1999 | 1264 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1992 | 534 | 0.010 |
Why?
|
Durapatite | 1 | 1992 | 163 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1992 | 1543 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13451 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 778 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40139 | 0.010 |
Why?
|
Molecular Weight | 1 | 1992 | 2186 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1744 | 0.010 |
Why?
|
Radiography | 1 | 2001 | 6965 | 0.010 |
Why?
|
Gene Library | 1 | 1992 | 1060 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1992 | 17624 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23374 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10185 | 0.010 |
Why?
|
Hemorrhage | 1 | 1981 | 3599 | 0.000 |
Why?
|
Calcium Channels | 1 | 1992 | 619 | 0.000 |
Why?
|
Heart Failure | 1 | 1992 | 11848 | 0.000 |
Why?
|
Mice | 1 | 2015 | 81209 | 0.000 |
Why?
|
Brain Diseases | 1 | 1996 | 1540 | 0.000 |
Why?
|
RNA, Messenger | 2 | 1992 | 12762 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1992 | 4169 | 0.000 |
Why?
|
Animals | 3 | 2015 | 167960 | 0.000 |
Why?
|
Rabbits | 1 | 1992 | 4773 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14661 | 0.000 |
Why?
|
Mexico | 1 | 1987 | 760 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1987 | 626 | 0.000 |
Why?
|
Kinetics | 1 | 1992 | 6377 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15286 | 0.000 |
Why?
|
Protein Conformation | 1 | 1992 | 3970 | 0.000 |
Why?
|
Coronary Disease | 1 | 1996 | 5991 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 12968 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1992 | 5132 | 0.000 |
Why?
|
Macaca | 1 | 1981 | 409 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1981 | 11890 | 0.000 |
Why?
|
Anticonvulsants | 1 | 1989 | 1879 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1989 | 6498 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1989 | 2907 | 0.000 |
Why?
|
Myocardial Revascularization | 1 | 1981 | 841 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1981 | 3112 | 0.000 |
Why?
|
Models, Biological | 1 | 1981 | 9468 | 0.000 |
Why?
|